Media Coverage

Our commercial intelligence and analysis are used by the Financial Times, the Wall Street Journal, Forbes, Nature, and Reuters, among others. Take a look at the latest Evaluate and Vantage coverage.

If you have questions about Evaluate or require data and expert insights to help support your editorial content, please see our Media Contacts.

Latest Media Coverage

Browse the archive

The Pharma Letter

Look back at pharma news in the week to August 2

Chalk up another flop in heart failure with preserved ejection fraction (HFpEF), this time for Novartis’s Entresto, commented Madeleine Armstrong on Vantage, the…

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.